1. NcicancerStats . Surveillance, epidemiology, and End results program. @NCICancerStats. https://seer.cancer.gov/index.html
Google Scholar2. Travis WD, International Agency for Research on, C . WHO classification of tumours of the lung, pleura, thymus and heart. World Health Organization classification of tumours. International Agency for Research on Cancer; 2015.
Google Scholar3. Kim, JY, Hong, SM, Ro, JY. Recent updates on grading and classification of neuroendocrine tumors. Ann Diagn Pathol. Aug 2017;29:11-16. doi:10.1016/j.anndiagpath.2017.04.005
Google Scholar | Crossref | Medline4. Metovic, J, Barella, M, Bianchi, F, et al. Morphologic and molecular classification of lung neuroendocrine neoplasms. Virchows Arch. Jan 2021;478(1):5-19. doi:10.1007/s00428-020-03015-z
Google Scholar | Crossref | Medline5. Bellizzi, AM . SATB2 In neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in merkel cell carcinoma among poorly differentiated carcinomas. Histopathology. Jan 2020;76(2):251-264. doi:10.1111/his.13943
Google Scholar | Crossref | Medline6. Fukuhara, M, Agnarsdottir, M, Edqvist, PH, Coter, A, Ponten, F. SATB2 Is expressed in merkel cell carcinoma. Arch Dermatol Res. Aug 2016;308(6):449-454. doi:10.1007/s00403-016-1655-6
Google Scholar | Crossref | Medline7. Hoskoppal, D, Epstein, JI, Gown, AM, et al. SATB2 Protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours. Histopathology. Mar 2020;76(4):550-559. doi:10.1111/his.14012
Google Scholar | Crossref | Medline8. Bellizzi, AM . Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you? Hum Pathol. Feb 2020;96:8-33. doi:10.1016/j.humpath.2019.12.002
Google Scholar | Crossref | Medline9. McFall, M, Mohanty, S, Liles, G, et al. Diagnostic utility of an expanded panel of novel and well-established immunohistochemical (IHC) markers to differentiate merkel cell carcinoma from high-grade non-merkel cell neuroendocrine carcinomas. Mod Pathol. 2014;27:129-145.
Google Scholar10. Shimizu, H, Endo, S, Natsugoe S, et al. Thoracic and cardiovascular surgery in Japan in 2016 : annual report by The Japanese association for thoracic surgery. Gen Thorac Cardiovasc Surg. Apr 2019;67(4):377-411. doi:10.1007/s11748-019-01068-9
Google Scholar | Crossref | Medline11. Bellizzi, AM . Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry. Adv Anat Pathol. Sep 2013;20(5):285-314. doi:10.1097/PAP.0b013e3182a2dc67
Google Scholar | Crossref | Medline12. Yatabe, Y, Dacic, S, Borczuk, AC, et al. Best practices recommendations for diagnostic immunohistochemistry in lung cancer. J Thorac Oncol. Mar 2019;14(3):377-407. doi:10.1016/j.jtho.2018.12.005
Google Scholar | Crossref | Medline13. Nicholson, SA, Beasley, MB, Brambilla, E, et al. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol. Sep 2002;26(9):1184-1197. doi:10.1097/00000478-200209000-00009
Google Scholar | Crossref | Medline14. Barbareschi, M, Murer, B, Colby, TV, et al. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol. Feb 2003;27(2):141-149. doi:10.1097/00000478-200302000-00001
Google Scholar | Crossref | Medline15. Hiroshima, K, Iyoda, A, Shida, T, et al. Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis. Mod Pathol. Oct 2006;19(10):1358-1368. doi:10.1038/modpathol.3800659
Google Scholar | Crossref | Medline | ISI16. Maleki, Z . Diagnostic issues with cytopathologic interpretation of lung neoplasms displaying high-grade basaloid or neuroendocrine morphology. Diagn Cytopathol. Mar 2011;39(3):159-167. doi:10.1002/dc.21351
Google Scholar | Crossref | Medline17. Bari, MF, Brown, H, Nicholson, AG, et al. BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas. Histopathology. Mar 2014;64(4):547-556. doi:10.1111/his.12278
Google Scholar | Crossref | Medline18. Rossi, G, Mengoli, MC, Cavazza, A, et al. Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology. Virchows Arch. Jan 2014;464(1):61-68. doi:10.1007/s00428-013-1501-6
Google Scholar | Crossref | Medline19. Yeh, YC, Chou, TY. Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses. J Surg Oncol. Mar 2014;109(3):280-286. doi:10.1002/jso.23497
Google Scholar | Crossref | Medline20. Lee, H, Fu, Z, Koo, BH, et al. The expression of TTF1, CDX2 and ISL1 in 74 poorly differentiated neuroendocrine carcinomas. Ann Diagn Pathol. Dec 2018;37:30-34. doi:10.1016/j.anndiagpath.2018.09.005
Google Scholar | Crossref | Medline21. Vrana, JA, Boland, JM, Terra, S, et al. SATB2 Is expressed in a subset of pulmonary and thymic neuroendocrine tumors. Am J Clin Pathol. Oct 13 2021;156(5):853-865. doi:10.1093/ajcp/aqab038.
Google Scholar | Crossref22. Britanova, O, Akopov, S, Lukyanov, S, Gruss, P, Tarabykin, V. Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissue-specific manner and demonstrates cell-type-dependent expression in the developing mouse CNS. Eur J Neurosci. Feb 2005;21(3):658-668. doi:10.1111/j.1460-9568.2005.03897.x
Google Scholar | Crossref | Medline23. Dobreva, G, Chahrour, M, Dautzenberg, M, et al. SATB2 Is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell. Jun 2 2006;125(5):971-986. doi:10.1016/j.cell.2006.05.012
Google Scholar | Crossref | Medline | ISI24. Dobreva, G, Dambacher, J, Grosschedl, R. SUMO Modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. Genes Dev. Dec 15 2003;17(24):3048-3061. doi:10.1101/gad.1153003
Google Scholar | Crossref | Medline25. Gyorgy, AB, Szemes, M, de Juan Romero, C, Tarabykin, V, Agoston, DV. SATB2 Interacts with chromatin-remodeling molecules in differentiating cortical neurons. Eur J Neurosci. Feb 2008;27(4):865-873. doi:10.1111/j.1460-9568.2008.06061.x
Google Scholar | Crossref | Medline26. Magnusson, K, de Wit, M, Brennan, DJ, et al. SATB2 In combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am J Surg Pathol. Jul 2011;35(7):937-948. doi:10.1097/PAS.0b013e31821c3dae
Google Scholar | Crossref | Medline27. Dragomir, A, de Wit, M, Johansson, C, Uhlen, M, Ponten, F. The role of SATB2 as a diagnostic marker for tumors of colorectal origin: results of a pathology-based clinical prospective study. Am J Clin Pathol. May 2014;141(5):630-638. doi:10.1309/AJCPWW2URZ9JKQJU
Google Scholar | Crossref | Medline28. Lin, F, Shi, J, Zhu, S, et al. Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine. Arch Pathol Lab Med. Aug 2014;138(8):1015-1026. doi:10.5858/arpa.2013-0452-OA
Google Scholar | Crossref | Medline29. Michele, DS, Katsyv, I, Purushothaman, S, Remotli, H. Immunohistochemical and mRNAAnalysis of SATB2 expression in neuroendocrine neoplasms of pancreas and midgut. Mod Pathol. 2020;33:1639-1640.
Google Scholar30. Lorentz, O, Duluc, I, Arcangelis, AD, Simon-Assmann, P, Kedinger, M, Freund, JN. Key role of the Cdx2 homeobox gene in extracellular matrix-mediated intestinal cell differentiation. J Cell Biol. Dec 15 1997;139(6):1553-1565. doi:10.1083/jcb.139.6.1553
Google Scholar | Crossref | Medline31. Savory, JG, Mansfield, M, Rijli, FM, Lohnes, D. Cdx mediates neural tube closure through transcriptional regulation of the planar cell polarity gene Ptk7. Development. Apr 2011;138(7):1361-1370. doi:10.1242/dev.056622
Google Scholar | Crossref | Medline32. Suh, E, Traber, PG. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol. Feb 1996;16(2):619-625. doi:10.1128/mcb.16.2.619
Google Scholar | Crossref | Medline33. Moskaluk, CA, Zhang, H, Powell, SM, Cerilli, LA, Hampton, GM, Frierson, HF. Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod Pathol. Sep 2003;16(9):913-919. doi:10.1097/01.MP.0000086073.92773.55
Google Scholar | Crossref | Medline34. Sivagnanasundaram, S, Islam, I, Talbot, I, Drummond, F, Walters, JR, Edwards, YH. The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis. Br J Cancer. Jan 2001;84(2):218-225. doi:10.1054/bjoc.2000.1544
Google Scholar | Crossref | Medline35. Moll, R, Lowe, A, Laufer, J, Franke, WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. Feb 1992;140(2):427-447.
Google Scholar | Medline36. Kriegsmann, M, Harms, A, Longuespee, R, et al. Role of conventional immunomarkers, HNF4–alpha and SATB2, in the differential diagnosis of pulmonary and colorectal adenocarcinomas. Histopathology. May 2018;72(6):997-1006. doi:10.1111/his.13455
Google Scholar | Crossref | Medline37. Vidarsdottir, H, Tran, L, Nodin, B, et al. Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases. Hum Pathol. Feb 2019;84:221-230. doi:10.1016/j.humpath.2018.10.009
Google Scholar | Crossref | Medline38. Bian, T, Zhao, J, Feng, J, et al. Combination of cadherin-17 and SATB homeobox 2 serves as potential optimal makers for the differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal adenocarcinoma. Oncotarget. Sep 2017;8(38):63442-63452. doi:10.18632/oncotarget.18828
Google Scholar | Crossref | Medline39. Matsushima, J, Yazawa, T, Suzuki, M, et al. Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and beta-catenin immunostaining for differentiation from metastatic colorectal carcinoma. Hum Pathol. Jun 2017;64:179-185. doi:10.1016/j.humpath.2017.04.006
Google Scholar | Crossref | Medline40. Inamura, K, Satoh, Y, Okumura, S, et al. Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas. Am J Surg Pathol. May 2005;29(5):660-665. doi:10.1097/01.pas.0000160438.00652.8b
Google Scholar | Crossref | Medline41. Wang, CX, Liu, B, Wang, YF, et al. Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases. Int J Clin Exp Pathol. 2014;7(3):1266-1274.
Google Scholar | Medline42. Bade, BC, Dela Cruz, CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. Mar 2020;41(1):1-24. doi:10.1016/j.ccm.2019.10.001
Google Scholar | Crossref | Medline43. Ou, SH, Ziogas, A, Zell, JA. Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity. J Thorac Oncol. Jan 2009;4(1):37-43. doi:10.1097/JTO.0b013e31819140fb
Google Scholar | Crossref | Medline44. Baine, MK, Hsieh, MS, Lai, WV, et al. SCLC Subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: a comprehensive immunohistochemical and histopathologic characterization. J Thorac Oncol. Dec 2020;15(12):1823-1835. doi:10.1016/j.jtho.2020.09.009
Google Scholar | Crossref | Medline45. Lantuejoul, S, Fernandez-Cuesta, L, Damiola, F, Girard, N, McLeer, A. New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts. Transl Lung Cancer Res. Oct 2020;9(5):2233-2244. doi: